Statistics
Publications
91
Citations
5.7K
H-Index
45
Active since
1983
Kevin R. Kelly is an author at The University of Texas at San Antonio Health Science Center specializing in medicine, oncology, and pharmacology.
Publications per year
1983–2024
91
91
Results of the Phase I Trial of RG7112, a Small-Molecule MDM2 Antagonist in Leukemia
Michael Andreeff, Kevin R. Kelly, Karen Yee et al. · Clinical Cancer Research · 2015 · 353 citations
Medicine, Oncology, Pharmacology +17
Inhibition of NEDD8-activating enzyme: a novel approach for the treatment of acute myeloid leukemia
Ronan Swords, Kevin R. Kelly, Peter G. Smith et al. · Blood · 2010 · 277 citations · Full text
Medicine, Oncology, Pharmacology +7
1–5 of 91